Risks Unique to SME IPOs
The potential for high returns in SME IPOs comes with a set of risks that do not exist — or exist in much milder form — in mainboard investing. Understanding these risks is not a reason to avoid SME IPOs. It is the prerequisite for investing in them intelligently.
Risk 1: Liquidity Risk — The Most Underestimated Danger
In mainboard stocks, you can typically sell any reasonable position within a trading session. In SME stocks, this is often not true.
Many SME-listed companies trade fewer than 10,000 shares per day. At a share price of ₹200, that is ₹20 lakh in daily volume. If you hold ₹5 lakh worth, selling in one day might move the price 5–10% against you.
This low liquidity has three practical consequences:
Exit difficulty: In a market downturn, SME stocks can become impossible to sell at any reasonable price. The bid-ask spread widens. The market maker may be the only buyer — at a significant discount to the last traded price.
Price manipulation vulnerability: Thin markets are easy to manipulate. Coordinated buying by a small group can drive SME prices up artificially; coordinated selling can crash them. Without institutional presence to provide stability, individual SME stocks can be subject to pump-and-dump schemes.
Forced holding: If you need to liquidate your portfolio urgently — for a medical emergency, a property purchase, or any cash need — SME positions may be unsellable at fair prices on short notice.
How to manage it: Invest in SME IPOs only with capital you genuinely can hold for 2–3 years. Never concentrate more in a single SME stock than you could comfortably hold indefinitely if the exit market dries up.
Risk 2: Promoter Concentration Risk
In large companies, ownership is diversified across thousands of institutional and retail investors. No single shareholder dominates decision-making.
In SME companies, promoters often own 50–70%+ of the company post-IPO. This concentration creates several risks:
Governance risk: With dominant ownership, promoters can make self-serving decisions — high related-party transactions, excessive promoter salaries, dilutive acquisitions — without meaningful shareholder pushback.
Key person risk: Many SME businesses are built around one or two individuals. If the founder-promoter exits the business — through personal issues, health, or simply losing interest after the IPO — the business can deteriorate rapidly.
Promoter exit risk: After lock-in periods expire, promoters with high holdings can create significant selling pressure. Watch lock-in expiry dates for high-OFS SME IPOs.
How to manage it: Read promoter backgrounds carefully. Check whether the promoter has a track record in this specific business (not just corporate directorships). Assess whether the business has a management layer below the founder.
Risk 3: Limited Financial Disclosure
SME-listed companies report financial results half-yearly, not quarterly. This means you may have stale financial data for months. By the time a problem in the business becomes visible in reported numbers, it may have been developing for 6 months.
Additionally, the financial reporting standards and audit quality for smaller companies can be lower. While all listed companies must use SEBI-registered auditors, the depth of scrutiny varies enormously between a Big Four audit of a large company and a regional CA firm auditing a ₹50 crore revenue SME.
How to manage it: Pay attention to auditor quality when reading the DRHP. Check auditor notes for qualifications or emphasis of matter paragraphs. After investment, track non-financial indicators — order wins, customer announcements, management interviews in trade media — to stay informed between financial reports.
Risk 4: Valuation Opacity
Mainboard IPOs are valued by reference to a reasonably well-defined peer group of listed companies with years of market history and analyst coverage. The valuation range is relatively anchored.
SME IPOs often have no directly listed peers. Valuation is established by the company and its merchant banker with significant discretion. Without comparable listed companies and without institutional investors to push back on aggressive pricing, some SME IPOs are priced at valuations that have no clear fundamental justification.
The result: more SME IPOs are mispriced (in either direction) than mainboard IPOs. Identifying underpriced SME IPOs is a genuine opportunity; overpaying for an overpriced one can result in permanent capital impairment.
How to manage it: Even without direct listed peers, you can value an SME company using absolute metrics: P/E vs the broader small-cap market, revenue multiples vs sector averages, growth rate vs price. An SME company growing 15% a year should not be priced at the same multiple as one growing 40%.
Risk 5: Sector and Business Model Risk
SME companies are, by definition, at an earlier stage of business development. This means:
- Concentration risk: Revenue often depends on a few large customers or a single product
- Geographic concentration: Many SMEs operate in one or two states, making them vulnerable to regional disruptions
- Technology disruption: Small companies in traditional industries can be disrupted faster than large incumbents with the resources to adapt
- Working capital cycles: SME businesses often have strained working capital, making them vulnerable to payment delays from large customers
How to manage it: Specifically check for customer concentration (top 5 customers as % of revenue) in the DRHP. A company deriving 80% of revenue from one customer is fundamentally riskier than one with diversified revenue.
Risk 6: Regulatory and Compliance Risk
Smaller companies sometimes have incomplete regulatory compliance — pending environmental clearances, GST disputes, labour law issues, or sector-specific licence requirements. These issues are disclosed in the DRHP but often not given sufficient weight by investors.
A regulatory disruption can materially impair a small business in ways that a large company can absorb.
How to manage it: Read the litigation and regulatory section of the DRHP carefully. For companies in regulated sectors (financial services, pharma, food processing), assess the regulatory compliance track record specifically.